ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2310건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1554 | Terminated | Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Drug: Dociparstat sodium Drug: Placebo |
Phase 3 | Chimerix | INDUSTRY | 27 | All | 18 Years ~ 85 Years | University of Alabama at Birmingham, Birmingham, Alabama, United States Advanced Pulmonary Research Institute/Wellington Regional Medical Center, Loxahatchee Groves, Florida, United States Augusta University, Augusta, Georgia, United States Our Lady of the Lake, Baton Rouge, Louisiana, United States Tulane University, New Orleans, Louisiana, United States University Medical Center, New Orleans, Louisiana, United States William Beaumont Hospital, Royal Oak, Michigan, United States Ascension Macomb-Oakland Cardiovascular Research, Warren, Michigan, United States Wake Forest Baptist Health, Winston-Salem, North Carolina, United States Texas Health Harris Methodist Hospital Fort Worth, Dallas, Texas, United States Ascension St. Francis Hospital, Milwaukee, Wisconsin, United States Ascension All Saints Hospital, Racine, Wisconsin, United States |
| 1553 | Completed | Donated Antibodies Working Against nCoV | COVID-19 | Biological: Convalescent Plasma Drug: Standard of care |
Phase 2 | Universitaire Ziekenhuizen KU Leuven, Federal Knowledge Centre (KCE) | OTHER | 483 | All | 18 Years | ZNA, Antwerpen, Belgium Imelda Ziekenhuis Bonheiden, Bonheiden, Belgium Institut Bordet, Brussel, Belgium UMC Sint-Pieter, Brussel, Belgium CHU Brugmann, Brussel, Belgium Erasmus Ziekenhuis, Brussel, Belgium UZ Brussel, Brussel, Belgium Cliniques Universitaires St Luc, Brussel, Belgium AZ Sint-Vincentius, Deinze, Belgium AZ Maria Middelares, Gent, Belgium AZ Sint-Lucas, Gent, Belgium AZ Groeninge, Kortrijk, Belgium UZ Leuven, Leuven, Belgium CHC Liege Mont Legia, Liege, Belgium CHR Citadelle Liege, Liege, Belgium CHU Liege Sart-Tilman, Liege, Belgium CHU Ambroise Pare, Mons, Belgium CHR Jolimont Mons-Hainaut, Mons, Belgium AZ Delta, Roeselare, Belgium Sint-Trudo Ziekenhuis, Sint-Truiden, Belgium Centre Hospitalier de Wallonie Picarde (CHwapi), Tournai, Belgium |
| 1552 | Unknown status | Dornase Alpha for the Treatment of COVID-19 | COVID-19 | Drug: Pulmozyme | Phase 2 | Acibadem University, The Scientific and Technological Research Council of Turkey | OTHER | 60 | All | 18 Years | Acıbadem Altunizade Hospital, Istanbul, Turkey |
| 1551 | Terminated | Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19 | Covid19 | Drug: XVR011 | Phase 2 | ExeVir Bio BV | INDUSTRY | 27 | All | 18 Years | Investigative Site, Ghent, Belgium Investigative Site, Liege, Belgium Investigative site, Mechelen, Belgium Investigative site, Milano, Italy Investigative Site, Roma, Italy Investigative site, Chisinau, Moldova, Republic of |
| 1550 | Withdrawn | Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19 | COVID-19 | Drug: Melatonin Drug: Placebo |
Phase 2 | State University of New York at Buffalo, National Center for Advancing Translational Sciences (NCATS) | OTHER | 0 | All | 18 Years | University at Buffalo, Buffalo, New York, United States |
| 1549 | Unknown status | Double Blind Randomized Clinical Trial of Use of Colchicine Added to Standard Treatment in Hospitalized With Covid-19 | COVID-19 Infection | Drug: Colchcine | Phase 3 | Biogipuzkoa Health Research Institute | OTHER | 752 | All | 18 Years ~ 99 Years | Biodonostia Health Research Institute, San Sebastian, Guipuzcoa, Spain |
| 1548 | Completed | Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19 | Coronavirus Disease 2019 | Drug: Placebos Drug: Leronlimab (700mg) |
Phase 2 | CytoDyn, Inc., Amarex Clinical Research | INDUSTRY | 56 | All | 18 Years | Arthritis & Rheumatic Disease Specialties, Aventura, Florida, United States Center for Advanced Research & Education (CARE), Gainesville, Georgia, United States |
